PharmaCyte Biotech (PMCB) Depreciation & Amortization (CF) (2010 - 2012)
PharmaCyte Biotech (PMCB) posted quarterly Depreciation & Amortization (CF) of $806.0 for Q2 2012, down 90.48% year-over-year from $8468.0 in Q2 2011, and down 89.21% quarter-over-quarter from $7473.0 in Q1 2012.
PharmaCyte Biotech (PMCB) Depreciation & Amortization (CF) (2010 - 2012) Analysis & Trends
PharmaCyte Biotech (PMCB) has reported Depreciation & Amortization (CF) for 3 consecutive years, with $806.0 the latest figure, recorded in Q2 2012.
- In Q2 2012, Depreciation & Amortization (CF) fell 90.48% year-over-year to $806.0; the TTM figure through Jan 2013 stood at $806.0 (down 97.51% YoY), while the FY2012 annual figure was $24659.0, down 39.39% from the prior year.
- Depreciation & Amortization (CF) slipped to $806.0 in Q2 2012 per PMCB's latest filing, from $7473.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $12024.0 in Q3 2010 and bottomed at $806.0 in Q2 2012.
- Historically, Depreciation & Amortization (CF) has averaged $8168.4 across 3 years, with a median of $8495.5 in 2011.
- On a YoY basis, Depreciation & Amortization (CF) climbed as much as 19.05% in 2012 and fell as far as 90.48% in 2012.
- PharmaCyte Biotech's Depreciation & Amortization (CF) stood at $10964.0 in 2010, then retreated by 28.34% to $7857.0 in 2011, then sank by 89.74% to $806.0 in 2012.
- Business Quant data shows PMCB's Depreciation & Amortization (CF) at $806.0 in Q2 2012, $7473.0 in Q1 2012, and $7857.0 in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 40.52 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 191.83 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | PharmaCyte Biotech | 4.38 Mn | 4.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2012 | 806.00 |
| Apr 30, 2012 | 806.00 |
| Jan 31, 2012 | 7,473.00 |
| Jan 31, 2012 | 7,473.00 |
| Oct 31, 2011 | 7,857.00 |
| Oct 31, 2011 | 7,857.00 |
| Jul 31, 2011 | 8,523.00 |
| Jul 31, 2011 | 8,523.00 |
| Apr 30, 2011 | 8,468.00 |
| Apr 30, 2011 | 8,468.00 |
| Jan 31, 2011 | 9,232.00 |
| Jan 31, 2011 | 9,232.00 |
| Oct 31, 2010 | 10,964.00 |
| Oct 31, 2010 | 10,964.00 |
| Jul 31, 2010 | 12,024.00 |
| Jul 31, 2010 | 12,024.00 |